Articles

CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2. 

Oragenics and Avid Bioservices Collaborate on Coronavirus Vaccine

BioMarin received the complete response letter for valoctocogene roxaparvovec, its gene therapy intended for treating severe hemophilia A.

FDA Issues Complete Response Letter to BioMarin for Hemophilia A Gene Therapy

UK government has set up a new organization to replace Public Health England.

UK Gov Sets Up New Public Health Organization

EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.

EC Reaches Agreement with AstraZeneca on Purchase of COVID-19 Vaccine

The UK's MHRA will resume on-site risk based GxP inspections from September 2020.

MHRA to Resume On-Site Inspections in September 2020

Avacta Group has expanded its drug development partnership with LG Chem Life Sciences to include new programs incorporating Avacta’s Affimer XT technology.

Avacta, LG Chem Life Sciences Expand Drug Development Agreement

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

CARBOGEN AMCIS Invests Heavily in Switzerland and France

Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial. 

Novavax Signs Term Sheet with UK Gov for COVID-19 Vaccine Doses

Bristol Myers Squibb will handle the development and commercialization of DF6002 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding, and manufacturing.

Bristol Myers Squibb and Dragonfly Therapeutics Form $475-Million Immunotherapy Deal

The collaboration will increase the supply of the potential treatment to at least three and a half times the current capacity.

News